FR2397385A1 - Derives du resorcinol, leur preparation et leurs utilisations therapeutiques - Google Patents

Derives du resorcinol, leur preparation et leurs utilisations therapeutiques

Info

Publication number
FR2397385A1
FR2397385A1 FR7713746A FR7713746A FR2397385A1 FR 2397385 A1 FR2397385 A1 FR 2397385A1 FR 7713746 A FR7713746 A FR 7713746A FR 7713746 A FR7713746 A FR 7713746A FR 2397385 A1 FR2397385 A1 FR 2397385A1
Authority
FR
France
Prior art keywords
preparation
therapeutic uses
resorcinol derivatives
resorcinol
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7713746A
Other languages
English (en)
Other versions
FR2397385B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of FR2397385A1 publication Critical patent/FR2397385A1/fr
Application granted granted Critical
Publication of FR2397385B1 publication Critical patent/FR2397385B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/65—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
    • C07C45/66—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups by dehydration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/794—Ketones containing a keto group bound to a six-membered aromatic ring having unsaturation outside an aromatic ring
    • C07C49/796—Ketones containing a keto group bound to a six-membered aromatic ring having unsaturation outside an aromatic ring polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/83—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

5-alkyl-résorcinols substitués en position 2, leur préparation et leurs utilisations thérapeutiques. Ces composés répondent à la formule :
FR7713746A 1975-11-14 1977-05-05 Derives du resorcinol, leur preparation et leurs utilisations therapeutiques Granted FR2397385A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/632,126 US4018777A (en) 1975-11-14 1975-11-14 2-Substituted-5-alkyl resorcinols

Publications (2)

Publication Number Publication Date
FR2397385A1 true FR2397385A1 (fr) 1979-02-09
FR2397385B1 FR2397385B1 (fr) 1980-04-25

Family

ID=24534181

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7633756A Granted FR2361887A1 (fr) 1975-11-14 1976-11-09 Derives du resorcinol, leur preparation et leurs utilisations therapeutiques
FR7713746A Granted FR2397385A1 (fr) 1975-11-14 1977-05-05 Derives du resorcinol, leur preparation et leurs utilisations therapeutiques

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR7633756A Granted FR2361887A1 (fr) 1975-11-14 1976-11-09 Derives du resorcinol, leur preparation et leurs utilisations therapeutiques

Country Status (18)

Country Link
US (1) US4018777A (fr)
JP (1) JPS5262254A (fr)
AU (1) AU511431B2 (fr)
CA (1) CA1090346A (fr)
CH (1) CH618427A5 (fr)
DE (1) DE2651708A1 (fr)
DK (1) DK506776A (fr)
FI (1) FI763241A (fr)
FR (2) FR2361887A1 (fr)
GB (1) GB1541858A (fr)
GR (1) GR61763B (fr)
MX (1) MX4120E (fr)
NL (1) NL7612607A (fr)
NO (1) NO146060C (fr)
PH (1) PH12341A (fr)
PT (1) PT65816B (fr)
SE (1) SE428800B (fr)
ZA (1) ZA766571B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
WO2002026224A2 (fr) * 2000-09-28 2002-04-04 Immugen Pharmaceuticals, Inc. Procedes et composes pour inhiber le metabolisme des eicosanoides et l'agregation plaquettaire
WO2002026728A2 (fr) * 2000-09-28 2002-04-04 Immugen Pharmaceuticals, Inc. Procedes antiviraux et composes
CN1652766A (zh) * 2002-03-18 2005-08-10 免疫力药品有限公司 间苯二酚和大麻素的局部制剂及其施用方法
CA2496097A1 (fr) * 2002-08-23 2004-03-04 University Of Connecticut Ceto-cannabinoides possedant des indications therapeutiques
CA2495903A1 (fr) * 2002-08-23 2004-03-04 University Of Connecticut Nouveaux cannabinoides biphenyle et de type biphenyle
JP5654608B2 (ja) * 2009-11-17 2015-01-14 ノバルティス アーゲー アルドステロンシンターゼ阻害剤としてのアリール−ピリジン誘導体
KR20200004792A (ko) * 2017-05-09 2020-01-14 에자이 알앤드디 매니지먼트 가부시키가이샤 피라노디피리딘 화합물의 결정
WO2020185661A1 (fr) * 2019-03-08 2020-09-17 The Regents Of The University Of California Utilisation de composés de 8,9-dihydrocannabidiol
CA3132861A1 (fr) * 2019-03-12 2020-09-17 6th Wave Innovations Corp. Polymeres a empreinte moleculaire pour l'extraction de cannabinoides et utilisations associees
EP4251600A2 (fr) 2020-11-24 2023-10-04 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Dérivés cannabinoïdes et leur utilisation dans le traitement de l'inflammation et/ou de la douleur et/ou de l'obésité

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2223042A1 (fr) * 1973-04-02 1974-10-25 Abbott Lab

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2223042A1 (fr) * 1973-04-02 1974-10-25 Abbott Lab

Also Published As

Publication number Publication date
ZA766571B (en) 1977-10-26
SE428800B (sv) 1983-07-25
SE7612620L (sv) 1977-05-15
DK506776A (da) 1977-05-15
NO146060B (no) 1982-04-13
JPS5262254A (en) 1977-05-23
AU511431B2 (en) 1980-08-21
FR2397385B1 (fr) 1980-04-25
FI763241A (fr) 1977-05-15
PT65816B (en) 1978-05-12
PT65816A (en) 1976-12-01
CH618427A5 (fr) 1980-07-31
NO763881L (fr) 1977-05-18
MX4120E (es) 1981-12-15
NL7612607A (nl) 1977-05-17
CA1090346A (fr) 1980-11-25
FR2361887B1 (fr) 1979-03-09
NO146060C (no) 1982-08-04
DE2651708A1 (de) 1977-05-18
PH12341A (en) 1979-01-16
AU2114877A (en) 1978-07-13
GB1541858A (en) 1979-03-07
FR2361887A1 (fr) 1978-03-17
US4018777A (en) 1977-04-19
GR61763B (en) 1979-01-09

Similar Documents

Publication Publication Date Title
FR2359115A1 (fr) Derives tetraalkyles de bis-cyclohexylamines et leur preparation
FR2372827A1 (fr) Composes polycycliques azotes et leurs utilisations therapeutiques comme hypotenseurs
FR2370732A1 (fr) Derives polysubstitues de la piperidine, leurs procedes de preparation et leur application en tant que medicaments
FR2354338A1 (fr) Acides n-phosphonomethylene-monoaminoalcane-mono- et polyphosphoniques et acides n-phosphonomethylene-diaminoalcane-polyphosphoniques, et leur preparation
FR2430418A1 (fr) Derives halogenomethyles d'a-aminoacides, leur preparation et leurs utilisations therapeutiques
FR2397385A1 (fr) Derives du resorcinol, leur preparation et leurs utilisations therapeutiques
FR2429797A1 (fr)
FR2417515A1 (fr) 13-alkylthio (et arylthio)-11,17-epoxy-17-methyl-18-norandrostenes et leurs utilisations therapeutiques
FR2427335A1 (fr) Derives du 5-nitro-imidazole, leur preparation et leurs utilisations comme medicaments antiprotozoaires
FR2422658A1 (fr) Composes piperazinyl-benzoheterocycliques, leur preparation et leurs utilisations therapeutiques
FR2377396A1 (fr) Dithienylalkylamines, leur preparation et leurs utilisations therapeutiques
FR2442226A1 (fr) Anilines substituees, leur preparation et leurs utilisations
FR2367742A1 (fr) Derives d'a-thio-alcanoiques, leur preparation et leur utilisation
FR2387215A1 (fr) 4-alcoylthio-2-trifluoromethylalcanesulfonanilides et leurs derives
FR2362852A1 (fr) Derives de la phenothiazine, leur preparation et leurs utilisations therapeutiques
FR2372164A1 (fr) Pyridobenzodiazepinones, leur preparation et leurs utilisations therapeutiques
FR2377386A1 (fr) Nouveaux derives de la pyrazoline, leur procede de preparation et leur application comme azureurs
FR2397405A1 (fr) Derives de la 2-pyridone utilisables comme regulateurs de la croissance des vegetaux
FR2372792A1 (fr) Aminoalcoxybenzenes, leur preparation et leurs utilisations therapeutiques
FR2395989A1 (fr) Derives diphenyle, leur preparation et leurs utilisations therapeutiques
FR2383163A1 (fr) Derives aromatiques et azotes de l'acetamide, leur preparation et leur utilisation therapeutique comme anti-arythmiques
FR2401922A1 (fr) Picolylamides d'acides 4-hydroxy-isophtaliques substitues, leur preparation et leurs utilisations therapeutiques
FR2391189A1 (fr) Derives de la 2-aminotetraline, leur preparation et leurs utilisations therapeutiques
FR2433516A1 (fr) Pyridoxines, leur preparation et leurs utilisations therapeutiques
FR2390435A1 (fr) Thiobenzylpyrimidines, leur preparation et leurs utilisations therapeutiques

Legal Events

Date Code Title Description
ST Notification of lapse